Understanding the effects of Alzheimer’s disease and TDP-43 protein inclusions on memory and cognition in older adults

Vulnerability Profiles of Comorbid Alzheimer and TDP-43 Proteinopathies in Amnestic Dementia

NIH-funded research Northwestern University at Chicago · NIH-10901010

This study is looking at how Alzheimer’s disease and a related protein issue affect thinking and memory in older adults, using brain samples from people who were tested for their mental abilities during their lives, to help us understand how these conditions impact brain health and behavior.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionNorthwestern University at Chicago NIH-funded
Lab location1 site (Chicago, United States)
Project IDNIH-10901010 on NIH RePORTER

What this research studies

This research investigates the combined effects of Alzheimer’s disease and TDP-43 proteinopathies on cognitive function in older adults. By analyzing brain specimens from individuals who underwent thorough neuropsychological testing during their lives, the study aims to identify specific clinical and biological markers associated with these conditions. The focus is on understanding how these overlapping pathologies impact memory, behavior, and overall brain health, particularly in key brain regions involved in cognition. This research utilizes extensive longitudinal data and advanced quantification techniques to provide insights into the mechanisms underlying these diseases.

Who could benefit from this research

Good fit: Ideal candidates for this research are older adults diagnosed with amnestic dementia and confirmed cases of Alzheimer’s disease.

Not a fit: Patients without cognitive impairment or those with other forms of dementia unrelated to Alzheimer’s or TDP-43 may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved diagnostic and therapeutic strategies for older adults suffering from cognitive decline due to Alzheimer’s disease and TDP-43 proteinopathies.

How similar studies have performed: Previous research has shown promising results in understanding the interplay between Alzheimer’s disease and other neurodegenerative conditions, suggesting that this approach could yield valuable insights.

Where this research is happening

Chicago, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndrome
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.